• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

丙戊酸盐剂量对肝毒性代谢物形成的影响。

Effect of valproate dose on formation of hepatotoxic metabolites.

作者信息

Anderson G D, Acheampong A A, Wilensky A J, Levy R H

机构信息

Department of Pharmaceutics, School of Pharmacy, University of Washington, Seattle 98195.

出版信息

Epilepsia. 1992 Jul-Aug;33(4):736-42. doi: 10.1111/j.1528-1157.1992.tb02355.x.

DOI:10.1111/j.1528-1157.1992.tb02355.x
PMID:1628592
Abstract

Valproate (VPA) therapy has been associated with a rare but fatal hepatotoxicity. 4-ene-VPA and 2(E),4-diene-VPA, unsaturated metabolites of VPA, are hepatotoxins several times more potent than VPA. In a previous study, a dose-dependent excretion of hepatotoxic metabolites was noted in patients receiving VPA. Our study was designed to evaluate the effect of dose on VPA metabolism under controlled conditions. Nineteen healthy volunteers sequentially received three different daily doses of VPA (250, 500, and 1,000 mg). Each dose was given twice daily for 4 days. Urine was collected for one dosage interval (12 h) at steady state for each dose and assayed for 15 VPA metabolites by gas chromatography/mass spectrometry (GCMS). Blood samples were also obtained from eight of the subjects, and VPA was assayed by GCMS. No effect of dose was noted on total plasma clearance. There was a significant dose-dependent decrease in intrinsic hepatic clearance. The intrinsic formation clearance (Clf) of the 4-ene-VPA pathway showed a statistically significant dose-dependent increase (0.22, 0.33, 0.40 ml/h/kg). The corresponding percentage of dose recovered as 4-ene-VPA and its sequential metabolites showed significant dose-dependent increases (0.15, 0.27, 0.62%). The role of VPA dose in the pathogenesis of hepatotoxicity may be more important than was previously believed.

摘要

丙戊酸盐(VPA)治疗与一种罕见但致命的肝毒性有关。VPA的不饱和代谢产物4-烯-VPA和2(E),4-二烯-VPA是比VPA毒性强几倍的肝毒素。在先前的一项研究中,接受VPA治疗的患者出现了肝毒性代谢产物的剂量依赖性排泄。我们的研究旨在评估在受控条件下剂量对VPA代谢的影响。19名健康志愿者依次接受三种不同的每日VPA剂量(250、500和1000毫克)。每种剂量每天给药两次,共4天。在每种剂量的稳态下收集一个给药间隔(12小时)的尿液,并通过气相色谱/质谱法(GCMS)分析15种VPA代谢产物。还从8名受试者中采集了血样,并通过GCMS分析VPA。未发现剂量对总血浆清除率有影响。肝内在清除率有显著的剂量依赖性降低。4-烯-VPA途径的内在生成清除率(Clf)显示出统计学上显著的剂量依赖性增加(0.22、0.33、0.40毫升/小时/千克)。作为4-烯-VPA及其后续代谢产物回收的相应剂量百分比显示出显著的剂量依赖性增加(0.15、0.27、0.62%)。VPA剂量在肝毒性发病机制中的作用可能比以前认为的更为重要。

相似文献

1
Effect of valproate dose on formation of hepatotoxic metabolites.丙戊酸盐剂量对肝毒性代谢物形成的影响。
Epilepsia. 1992 Jul-Aug;33(4):736-42. doi: 10.1111/j.1528-1157.1992.tb02355.x.
2
Effects of polytherapy with phenytoin, carbamazepine, and stiripentol on formation of 4-ene-valproate, a hepatotoxic metabolite of valproic acid.苯妥英钠、卡马西平和司替戊醇联合治疗对丙戊酸肝毒性代谢产物4-烯-丙戊酸形成的影响。
Clin Pharmacol Ther. 1990 Sep;48(3):225-35. doi: 10.1038/clpt.1990.144.
3
Associations of CYP2C9 and CYP2A6 Polymorphisms with the Concentrations of Valproate and its Hepatotoxin Metabolites and Valproate-Induced Hepatotoxicity.CYP2C9和CYP2A6基因多态性与丙戊酸盐及其肝毒素代谢产物浓度以及丙戊酸盐诱导的肝毒性的相关性。
Basic Clin Pharmacol Toxicol. 2017 Aug;121(2):138-143. doi: 10.1111/bcpt.12776. Epub 2017 May 3.
4
The relationship between glucuronide conjugate levels and hepatotoxicity after oral administration of valproic acid.口服丙戊酸后葡糖醛酸结合物水平与肝毒性之间的关系。
Arch Pharm Res. 2009 Jul;32(7):1029-35. doi: 10.1007/s12272-009-1708-x. Epub 2009 Jul 31.
5
Dose-dependent pharmacokinetics of toxic metabolites is not related to increased toxicity following high-dose valproic acid in rats.高剂量丙戊酸在大鼠体内引起的毒性代谢物的剂量依赖性药代动力学与毒性增加无关。
J Appl Toxicol. 2010 Nov;30(8):775-8. doi: 10.1002/jat.1608.
6
Associations between risk factors for valproate hepatotoxicity and altered valproate metabolism.丙戊酸肝毒性危险因素与丙戊酸代谢改变之间的关联。
Epilepsia. 1992 Jan-Feb;33(1):172-7. doi: 10.1111/j.1528-1157.1992.tb02302.x.
7
Valproate (VPA) metabolites in various clinical conditions of probable VPA-associated hepatotoxicity.丙戊酸盐(VPA)在各种可能与VPA相关肝毒性临床状况下的代谢产物。
Epilepsia. 1993 Mar-Apr;34(2):332-46. doi: 10.1111/j.1528-1157.1993.tb02419.x.
8
Fluorinated analogues as mechanistic probes in valproic acid hepatotoxicity: hepatic microvesicular steatosis and glutathione status.氟化类似物作为丙戊酸肝毒性的机制探针:肝脏微泡性脂肪变性和谷胱甘肽状态
Chem Res Toxicol. 1995 Jul-Aug;8(5):671-82. doi: 10.1021/tx00047a006.
9
Valproate metabolites in serum and urine during antiepileptic therapy in children with infantile spasms: abnormal metabolite pattern associated with reversible hepatotoxicity.婴儿痉挛症患儿抗癫痫治疗期间血清和尿液中的丙戊酸代谢物:与可逆性肝毒性相关的异常代谢物模式
Epilepsia. 1992 Jan-Feb;33(1):165-71. doi: 10.1111/j.1528-1157.1992.tb02301.x.
10
Effects of valproate and E-2-en-valproate on functional and morphological parameters of rat liver. I. Biochemical, histopathological and pharmacokinetic studies.丙戊酸盐和E-2-烯丙戊酸盐对大鼠肝脏功能和形态学参数的影响。I. 生化、组织病理学和药代动力学研究。
Epilepsy Res. 1992 Dec;13(3):187-98. doi: 10.1016/0920-1211(92)90052-u.

引用本文的文献

1
Valproate Damaging Effect on Erythrocyte Metabolism as a Decisive Factor in the Development of Encephalopathy.丙戊酸盐对红细胞代谢的损害作用是脑病发生发展的决定性因素。
Biomolecules. 2025 Apr 15;15(4):588. doi: 10.3390/biom15040588.
2
Ammoniagenic Action of Valproate without Signs of Hepatic Dysfunction in Rats: Possible Causes and Supporting Evidence.丙戊酸盐的氨生成作用而无肝功能障碍的迹象在大鼠中:可能的原因和支持证据。
Biomolecules. 2024 Mar 19;14(3):370. doi: 10.3390/biom14030370.
3
The role of efflux transporters and metabolizing enzymes in brain and peripheral organs to explain drug-resistant epilepsy.
外排转运体和代谢酶在脑和外周器官中的作用,以解释耐药性癫痫。
Epilepsia Open. 2022 Aug;7 Suppl 1(Suppl 1):S47-S58. doi: 10.1002/epi4.12542. Epub 2021 Oct 1.
4
Post-stroke Delivery of Valproic Acid Promotes Functional Recovery and Differentially Modifies Responses of Peri-Infarct Microglia.中风后给予丙戊酸可促进功能恢复并差异性改变梗死灶周围小胶质细胞的反应。
Front Mol Neurosci. 2021 May 28;14:639145. doi: 10.3389/fnmol.2021.639145. eCollection 2021.
5
-Inositol and Its Derivatives: Their Emerging Role in the Treatment of Human Diseases.肌醇及其衍生物:它们在人类疾病治疗中的新作用。
Front Pharmacol. 2019 Oct 11;10:1172. doi: 10.3389/fphar.2019.01172. eCollection 2019.
6
Pharmacokinetic interactions of topiramate.托吡酯的药代动力学相互作用。
Clin Pharmacokinet. 2004;43(12):763-80. doi: 10.2165/00003088-200443120-00001.
7
Establishing individual metabolite patterns for patients on valproate therapy.为接受丙戊酸盐治疗的患者建立个体代谢物模式。
Eur J Drug Metab Pharmacokinet. 2001 Jan-Jun;26(1-2):99-107. doi: 10.1007/BF03190383.